The Claim
In human hepatoma HepG2 cells exposed to high glucose (25 mM), sulforaphane (10 μM) increases reduced glutathione levels by 20-fold through upregulation of glutathione biosynthetic genes GCLM and GCLC and enhanced cysteine import via SLC7A11.
What the research says
Not yet evaluated
We are still looking at what the research says.
These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.
In liver cancer cells under high sugar conditions, sulforaphane at a specific dose doubles the amount of reduced glutathione by activating genes that produce it and increasing the uptake of cysteine, a key building block.
See the scientific wording
In human hepatoma HepG2 cells exposed to high glucose (25 mM), sulforaphane (10 μM) increases reduced glutathione levels by 20-fold, primarily by upregulating glutathione biosynthetic genes (GCLM, GCLC) and enhancing cysteine import via SLC7A11, which supports antioxidant defense under metabolic stress.
Sulforaphane triggers a cellular defense system that increases the production of a key antioxidant called glutathione by turning on genes that make its building blocks and improving the supply of one critical ingredient, cysteine. It also redirects sugar metabolism to generate the energy needed to keep glutathione active, allowing cells to survive high sugar levels without damage.
What the research says
1 studyIn liver cells flooded with sugar, sulforaphane from broccoli turns on genes that make more of a natural antioxidant called glutathione and helps bring in more of its building blocks, helping the cells fight off damage.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.